Dr. Mark Donaldson received his B.Sc.(Pharm.) from the University of British Columbia and his Doctorate in Clinical Pharmacy from the University of Washington.
He has further completed a residency at Canadašs largest tertiary care facility, Vancouver General Hospital, and is the current Director of Pharmaceutical Services
at the Kalispell Regional Medical Center.
Dr. Donaldson is a faculty member and Clinical Assistant Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Assistant Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He is also a continuing education speaker for the University of Washington, Washington State University, Oregon Health Sciences University, the Duke School of Medicine, The New York University, the University of British Columbia.
Dr. Donaldson has a special interest in dental pharmacology and has lectured internationally on a number of related topics for both dental and medical practitioners. He has been a primary author and investigator for the National Institutes of Health (N.I.H.) Consensus Development Committee to define the guidelines for enteral sedation in the United States, as well as an invited expert to compose a whitepaper on Enteral Conscious Sedation for the Academy of General Dentistry (AGD). Dr. Donaldson has a number of published works in the peer-reviewed literature, and has spent three years in Japan focussing on cross-cultural communication and internationalization.